February 29, 2020

February 28, 2020

Subscribe to Latest Legal News and Analysis

February 27, 2020

Subscribe to Latest Legal News and Analysis

February 26, 2020

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as  an ex parte appeal from denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent-filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade-secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

Date Title Organization
28
Feb
TSLE Podcast Episode 18: The Value of Explaining What Your Trade Secret Does, Reasonable Efforts to Maintain Secrecy, and 'Improper Means' [PODCAST] Greenberg Traurig, LLP
27
Feb
Chinese Trademark Office Cracks Down on Malicious Filing of Coronavirus-Related Trademarks Schwegman, Lundberg & Woessner, P.A.
27
Feb
Maximizing Your IP Protections in Digital Health McDermott Will & Emery
27
Feb
Petitioner’s Reply Argument in IPR Is Not an Impermissible New Theory McDermott Will & Emery
27
Feb
Federal Circuit Confirms Time Bar Under § 315(b) Is Waivable McDermott Will & Emery
27
Feb
Antitrust Byte: FDA and FTC Join Forces to Promote Biosimilars Epstein Becker & Green, P.C.
27
Feb
Top Legal Issues Facing the Automotive Industry in 2020 Foley & Lardner LLP
26
Feb
Shanghai People’s Procuratorate Launches Criminal Prosecution of Lego Block Infringers Schwegman, Lundberg & Woessner, P.A.
26
Feb
Too little, too late: Federal Circuit holds that cessation of sales does not alleviate patentee’s affirmative duty to mark Mintz
25
Feb
Necessity Is The Mother Of Single Reference Anticipation By Inherency Foley & Lardner LLP
25
Feb
2019 IP Law Year in Review: Copyrights McDermott Will & Emery
25
Feb
Chinese Patent Filings Show Uptick in January 2020 Schwegman, Lundberg & Woessner, P.A.
25
Feb
The Defend Trade Secrets Act (DTSA) Can Apply To Acts of Misappropriation Occurring Entirely Outside the United States Squire Patton Boggs (US) LLP
24
Feb
Anticompetitive Patent-Listing Decision May Clear Patent Thicket for Generic Pharma Industry Schiff Hardin LLP
23
Feb
As broad as it is long: CJEU rules that trade mark owners need not amend broad specifications Squire Patton Boggs (US) LLP
22
Feb
Delaware Provides More Insight into the Scope of the Rights Derived by a Patent Term Extension Squire Patton Boggs (US) LLP
21
Feb
Protecting Your Tech: IP Considerations in Digital Health McDermott Will & Emery
20
Feb
Trademark Showdown: Inter Milan and Inter Miami Battle over the Rights to “Inter” Squire Patton Boggs (US) LLP
20
Feb
A Lot of Hot Air? Obviousness Testimony Must Come from POSITA McDermott Will & Emery
20
Feb
All in the Family: Prior Patent License Implicitly Grants License to Asserted Patent McDermott Will & Emery

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS